Navigation Links
iMD Companies Inc. receives shares of Positive Solutions
Date:8/2/2012

TAMPA, Fla., Aug. 2, 2012 /PRNewswire/ -- By action of its Board of Directors, Positive Solutions Clinics, Inc., the subsidiary encompassing the adult & pediatric weight loss and wellness centers as well as the supplement divisions of iMD, issued 30 million shares of common stock to iMD Companies, Inc. (ICBU).  As part of the company's continued reorganization strategy begun earlier this year, Positive Solutions issued the shares to iMD Companies (ICBU), making it the sole shareholder.  iMD now owns 30 million shares of the 50 million shares of common stock authorized by the Board of Positive Solutions.

ABOUT IMD Companies, Inc.

IMD Companies, Inc., (OTC MARKETS:ICBU) is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. Its primary products and services lie in the health and fitness nutraceutical and medical diagnostics services markets. The company has also expanded into the weight-loss industry. The company delivers its medical diagnostic services on-site at participating medical clinics and physician offices. The nutraceutical supplements, pills, bar and gels will be marketed and distributed through participating clinics and on-line web marketing retail methods.  The company will continue to develop its innovative marketing strategies, including the use of social networking vehicles.

Safe Harbor Statement:

Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.


'/>"/>
SOURCE iMD Companies Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Companies Reports Second Quarter 2012 Results
2. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
3. Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
4. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
5. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
6. Info Graphic: Middle managers are frozen by information overload, costing companies millions
7. Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com
8. Par Pharmaceutical Companies to Report Second Quarter 2012 Results on August 2, 2012
9. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
10. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
11. Par Pharmaceutical Companies Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... 2017 , ... Brady (NYSE:BRC), a global leader in industrial and ... B-7569 vinyl label materials received certification for the BS5609 British Marine Standard. This ... and legible, for use on chemical drums shipped by sea. , “Achieving ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency ... (AOR) for Theravent, Inc. , the makers of a revolutionary new device ... Healthcare, is now working to expand distribution in anticipation of a national launch. ...
(Date:4/21/2017)... Dallas, TX (PRWEB) , ... April 21, 2017 ... ... Sleep Care products, announced an exciting new partnership with the highly regarded and ... of Airway Management’s highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and ...
(Date:4/21/2017)... Lake City, UT (PRWEB) , ... April 21, 2017 , ... ... staffing solutions, recently partnered with Advanced Patient Care of Utah (APCUT) and has appointed ... way for the next chapter of growth for our agency and our ability to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... are five common elements between the Obamacare program that most Republicans love to ... uses Warfarin poison to kill hogs. , Like Obamacare, the Miller program ...
Breaking Medicine News(10 mins):